Milene Volpato

Publication Activity (10 Years)

Years Active: 2020-2020
Publications (10 Years): 3

Top Topics

Endoplasmic Reticulum

Positive Breast Cancer

Top Venues

Cancer chemotherapy and pharmacology

Exploration of targeted anti-tumor therapy

University of Leeds

University of Bradford Institute of Cancer Therapeutics (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Leeds Jan 01 2020

United Kingdom

Lecturer :: Leeds Institute of Medical Research

University of Leeds Oct 01 2010

United Kingdom

Research Fellow :: Molecular Gastroenterology, LIBACS

University of Leeds Oct 01 2007 - Sep 30 2010

United Kingdom

Research Fellow :: Experimental Therapeutics

University of Bradford Institute of Cancer Therapeutics Jun 01 2005 - Sep 30 2007

United Kingdom

Postdoctoral research assistant

Education History

University of Bradford Institute of Cancer Therapeutics Sep 13 2001 - May 30 2005

United Kingdom

PHD :: Cancer Research Unit

Publications

Milene Volpato, Michele Cummings, Abeer M Shaaban, Balkees Abderrahman, Mark A Hull, Philipp Y Maximov, Bradley M Broom, Reiner Hoppe, Ping Fan, Hiltrud B Brauch, V Craig Jordan, Valerie Speirs
Downregulation of 15-hydroxyprostaglandin dehydrogenase during acquired tamoxifen resistance and association with poor prognosis in ERα-positive breast cancer. Exploration of targeted anti-tumor therapy 1 (2020)
Milene Volpato, Nicola Ingram, Sarah L Perry, Jade Spencer, Amanda D Race, Catriona Marshall, John M Hutchinson, Anna Nicolaou, Paul M Loadman, P Louise Coletta, Mark A Hull
Correction to: Cyclooxygenase activity mediates colorectal cancer cell resistance to the omega‑3 polyunsaturated fatty acid eicosapentaenoic acid. Cancer chemotherapy and pharmacology (2020)
Milene Volpato, Nicola Ingram, Sarah L Perry, Jade Spencer, Amanda D Race, Catriona Marshall, John M Hutchinson, Anna Nicolaou, Paul M Loadman, P Louise Coletta, Mark A Hull
Cyclooxygenase activity mediates colorectal cancer cell resistance to the omega-3 polyunsaturated fatty acid eicosapentaenoic acid. Cancer chemotherapy and pharmacology 87 (2) (2020)